DOCIVYX

NDC 83831-102 · Avyxa Pharma, LLC

Generic namedocetaxel

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DOCETAXEL

Strength80 mg/8mL

Pharmacologic classMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]

Marketing categoryNDA

Packages

83831-102-08 — 1 VIAL, GLASS in 1 CARTON (83831-102-08) / 8 mL in 1 VIAL, GLASS

Billed under HCPCS

J9172 — Injection, docetaxel (docivyx), 1 mg Medicare Part B payment limit (ASP + 6%): $46.19

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

23155-905 — Docetaxel, 43066-001 — docetaxel, 43066-006 — docetaxel, 43066-010 — docetaxel, 43598-258 — Docetaxel, 43598-259 — Docetaxel, 43598-389 — Docetaxel, 43598-610 — Docetaxel, 43598-611 — Docetaxel, 45963-734 — Docetaxel, 45963-765 — Docetaxel, 57884-3041 — Docetaxel, 57884-3042 — Docetaxel, 57884-3043 — Docetaxel, 66758-050 — docetaxel, 67457-781 — Docetaxel, 71288-133 — Docetaxel, 71288-152 — Docetaxel, 83831-101 — docetaxel, 83831-103 — docetaxel, +13 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources